FDA NDC Directory · JSON-LD · Markdown
NDC 54092-385 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE
| Generic name | Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine Aspartate |
|---|---|
| Labeler / Manufacturer | Takeda Pharmaceuticals America, Inc. |
| Marketing category | New Drug Application (innovator) · App NDA021303 |
| Dosage form / route | CAPSULE, EXTENDED RELEASE · ORAL |
| Active ingredients | AMPHETAMINE ASPARTATE MONOHYDRATE (3.75 mg/1) AMPHETAMINE SULFATE (3.75 mg/1) DEXTROAMPHETAMINE SACCHARATE (3.75 mg/1) DEXTROAMPHETAMINE SULFATE (3.75 mg/1) |
| Marketing started | 20020522 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).